Singhal Anil K. 4
4 · Werewolf Therapeutics, Inc. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
Singhal Anil K.
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-19+45,000→ 45,000 totalExercise: $1.40Exp: 2035-02-18→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 19, 2025. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.